Related Experiment Video
Updated: Mar 22, 2026

Author Spotlight: Advancing Type 1 Diabetes Research Using Innovative Pancreatic Slice Platforms
Published on: March 15, 2024
Diabetes 2030: Insights from Yesterday, Today, and Future Trends
William R Rowley1, Clement Bezold1, Yasemin Arikan1
11 Institute for Alternative Futures , Alexandria, Virginia.
Diabetes prevalence in the US is projected to increase by 54% by 2030, leading to more deaths and higher costs, despite medical advances. Prevention programs are crucial to mitigate these trends.
Area of Science:
- Public Health
- Epidemiology
- Health Economics
Background:
- Diabetes is a significant and growing public health concern in the United States.
- Current trends indicate a worsening crisis despite ongoing medical advancements and prevention initiatives.
Purpose of the Study:
- To forecast future trends in diabetes prevalence, morbidity, and associated costs in the U.S. up to 2030.
- To update and extend the diabetes forecasting model for national, state, and metropolitan area projections.
Main Methods:
- Utilized an updated diabetes forecasting model.
- Incorporated data sources for national, state, and metropolitan area projections.
- Analyzed trends in prevalence, morbidity, mortality, and costs.
Main Results:
- Diabetes prevalence projected to increase by 54% to over 54.9 million Americans by 2030.
- Annual diabetes-related deaths expected to rise by 38% to 385,800.
- Total annual costs associated with diabetes projected to increase by 53% to over $622 billion by 2030.
Conclusions:
- Diabetes will remain a major health crisis in the U.S. through 2030.
- Increased longevity due to improved management will lead to higher long-term costs.
- Aggressive population health measures, including diabetes prevention programs, are essential to alter these projections.
More Related Videos
10:35Extracellular Glucose Depletion as an Indirect Measure of Glucose Uptake in Cells and Tissues Ex Vivo
Published on: April 6, 2022
08:13Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test OGTT and Insulin Tolerance Test ITT
Published on: January 7, 2018
Related Concept Videos
Diabetes: Symptoms, Diagnosis, and Complications
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes Mellitus: Type 2 and Gestational
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...